Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype
- 15 June 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (12) , 3646-3651
- https://doi.org/10.1016/j.bmcl.2008.04.065
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Kinetic Characterization and Molecular Docking of a Novel, Potent, and Selective Slow-Binding Inhibitor of Human Cathepsin LMolecular Pharmacology, 2008
- Identification and synthesis of a unique thiocarbazate cathepsin L inhibitorBioorganic & Medicinal Chemistry Letters, 2008
- Proteolysis of the Ebola Virus Glycoproteins Enhances Virus Binding and InfectivityJournal of Virology, 2007
- Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: The confounding effects of DTT and cysteine in biological assaysBioorganic & Medicinal Chemistry Letters, 2007
- Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus GlycoproteinJournal of Virology, 2006
- Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for InfectionScience, 2005
- A Simple Key for Benzylic Mono- and gem-Dibromination of Primary Aromatic Amine Derivatives Using Molecular BromineSynthesis, 2002
- Inhibition Mechanism of Cathepsin L-Specific Inhibitors Based on the Crystal Structure of Papain–CLIK148 ComplexBiochemical and Biophysical Research Communications, 1999
- Cysteine Proteinase Inhibitors Decrease Articular Cartilage and Bone Destruction in Chronic Inflammatory ArthritisArthritis & Rheumatism, 1994
- Cysteine protease inhibition by azapeptide estersJournal of Medicinal Chemistry, 1992